SCHEMBL13675694

SCHEMBL13675694

COc1ccc(-c2nc(NCc3ccccc3)c(C)s2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK4 Q9HAZ1 1/20 0.52
CDC7 O00311 1/20 0.51
DBF4 Q9UBU7 1/20 0.51
ACP1 P24666 2/20 0.50
SLC2A1 P11166 2/20 0.49
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
APP P05067 1/20 0.49
KDM4E B2RXH2 3/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
POLB P06746 1/20 0.48
RXFP1 Q9HBX9 1/20 0.48
EGFR P00533 3/20 0.48
NR1H4 Q96RI1 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
MAPT P10636 2/20 0.48
ALDH1A1 P00352 1/20 0.48
MAPK1 P28482 1/20 0.48
HTT P42858 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3864037 0.83 CDC7 (0.64) CLK4CDC7DBF4ACP1SLC2A1
SCHEMBL6704272 0.74 ACP1 (0.54) CLK4ACP1SLC2A1APPKDM4E
SCHEMBL5906677 0.74 APP (0.61) ACP1NPC1RAB9AAPPKDM4E
SCHEMBL11368657 0.74 PTGS2 (0.65) CLK4ACP1NPC1RAB9AKDM4E
SCHEMBL13325954 0.74 APP (0.67) CLK4ACP1SLC2A1APPSMN1; SMN2
SCHEMBL12176088 0.73 LMNA (0.76) CLK4ACP1SLC2A1APPMEN1
SCHEMBL9436438 0.72 ALOX5 (0.66) NPC1RAB9AAPPKDM4ESMN1; SMN2
SCHEMBL27968542 0.72 RAB9A (0.59) CLK4ACP1SLC2A1NPC1RAB9A
SCHEMBL4492481 0.71 GAA (0.48) CLK4NPC1APPKDM4EMEN1
SCHEMBL28681917 0.71 HPGD (0.74) ACP1KDM4EMEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270456-A1 Novel chemical compounds HASEGAWA MASAICHI 2009-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270456-A1 Novel chemical compounds HIPK3, HIPK2, HIPK1 CLK4 237/4885CDC7 175/4885DBF4 2235/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.